{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T16:58:34Z","timestamp":1772211514536,"version":"3.50.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","award":["Molkentin Investigator"],"award-info":[{"award-number":["Molkentin Investigator"]}],"id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007172","name":"Cincinnati Children\u2019s Hospital Medical Center","doi-asserted-by":"publisher","award":["Internal RIP funding to Molkentin"],"award-info":[{"award-number":["Internal RIP funding to Molkentin"]}],"id":[{"id":"10.13039\/100007172","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012218","name":"john hauck foundation","doi-asserted-by":"publisher","award":["general support"],"award-info":[{"award-number":["general support"]}],"id":[{"id":"10.13039\/100012218","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The world is currently in a pandemic of COVID-19 (Coronavirus disease-2019) caused by a novel positive-sense, single-stranded RNA \u03b2-coronavirus referred to as SARS-CoV-2. Here we investigated rates of SARS-CoV-2 infection in the greater Cincinnati, Ohio, USA metropolitan area from August 13 to December 8, 2020, just prior to initiation of the national vaccination program. Examination of 9,550 adult blood donor volunteers for serum IgG antibody positivity against the SARS-CoV-2 Spike protein showed an overall prevalence of 8.40%, measured as 7.56% in the first 58 days and 9.24% in the last 58 days, and 12.86% in December 2020, which we extrapolated to ~20% as of March, 2021. Males and females showed similar rates of past infection, and rates among Hispanic or Latinos, African Americans and Whites were also investigated. Donors under 30 years of age had the highest rates of past infection, while those over 60 had the lowest. Geographic analysis showed higher rates of infectivity on the West side of Cincinnati compared with the East side (split by I-75) and the lowest rates in the adjoining region of Kentucky (across the Ohio river). These results in regional seroprevalence will help inform efforts to best achieve herd immunity in conjunction with the national vaccination campaign.<\/jats:p>","DOI":"10.1371\/journal.pone.0254667","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T13:29:39Z","timestamp":1626269379000},"page":"e0254667","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020"],"prefix":"10.1371","volume":"16","author":[{"given":"Greg","family":"Davis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3174-0306","authenticated-orcid":true,"given":"Allen J.","family":"York","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willis Clark","family":"Bacon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suh-Chin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica Malone","family":"McNeal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5973-5058","authenticated-orcid":true,"given":"Alexander E.","family":"Yarawsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph J.","family":"Maciag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanette L. C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn C. S.","family":"Locker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyssa","family":"Sproles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Steve","family":"Woodle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen","family":"Safier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine A.","family":"Justus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Spearman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell E.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Cancelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael B.","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3598-3399","authenticated-orcid":true,"given":"Andrew B.","family":"Herr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Hildeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3558-6529","authenticated-orcid":true,"given":"Jeffery D.","family":"Molkentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"issue":"8","key":"pone.0254667.ref001","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"China Novel Coronavirus Investigating and Research Team","year":"2020","journal-title":"N Engl J Med"},{"issue":"7798","key":"pone.0254667.ref002","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"F Wu","year":"2020","journal-title":"Nature"},{"key":"pone.0254667.ref003","unstructured":"https:\/\/covid.cdc.gov\/covid-data-tracker\/#cases_casesper100klast7days."},{"issue":"2","key":"pone.0254667.ref004","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/vaccines8020236","article-title":"Dynamics of Population Immunity Due to the Herd Effect in the COVID-19 Pandemic","volume":"8","author":"VJ Clemente-Su\u00e1rez","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"pone.0254667.ref005","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.addr.2020.12.006","article-title":"Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection","volume":"169","author":"CJ Batty","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"pone.0254667.ref006","article-title":"Reinfection Rates among Patients who Previously Tested Positive for Coronavirus Disease 2019: a Retrospective Cohort Study","author":"MM Sheehan","year":"2021","journal-title":"Clin Infect Dis"},{"key":"pone.0254667.ref007","first-page":"1","article-title":"Immunological considerations for COVID-19 vaccine strategies","author":"M Jeyanathan","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"pone.0254667.ref008","first-page":"1","article-title":"Viral targets for vaccines against COVID-19","author":"L Dai","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"pone.0254667.ref009","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"F Amanat","year":"2020","journal-title":"Nat Med"},{"issue":"1","key":"pone.0254667.ref010","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1002\/cpmc.100","article-title":"SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup","volume":"57","author":"D Stadlbauer","year":"2020","journal-title":"Curr Protoc Microbiol"},{"key":"pone.0254667.ref011","doi-asserted-by":"crossref","first-page":"104754","DOI":"10.1016\/j.jcv.2021.104754","article-title":"Interactions between seasonal human coronaviruses and implications for the SARS-CoV-2 pandemic: A retrospective study in Stockholm, Sweden, 2009\u20132020","volume":"136","author":"R Dyrdak","year":"2021","journal-title":"J Clin Virol"},{"key":"pone.0254667.ref012","doi-asserted-by":"crossref","first-page":"594439","DOI":"10.3389\/fmed.2020.594439","article-title":"Structural Comparison of the SARS CoV 2 Spike Protein Relative to Other Human-Infecting Coronaviruses","volume":"7","author":"ME Cueno","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"pone.0254667.ref013","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0006-3495(00)76713-0","article-title":"Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling","volume":"78","author":"P Schuck","year":"2000","journal-title":"Biophys J"},{"issue":"1\u20133","key":"pone.0254667.ref014","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bpc.2003.10.027","article-title":"Sedimentation velocity, multi-speed method for analyzing polydisperse solutions","volume":"108","author":"WF Stafford","year":"2004","journal-title":"Biophys Chem"},{"issue":"2","key":"pone.0254667.ref015","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ab.2006.04.053","article-title":"Improved methods for fitting sedimentation coefficient distributions derived by time-derivative techniques","volume":"354","author":"JS Philo","year":"2006","journal-title":"Anal Biochem"},{"issue":"54","key":"pone.0254667.ref016","doi-asserted-by":"crossref","first-page":"eabe0240","DOI":"10.1126\/sciimmunol.abe0240","article-title":"Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome","volume":"5","author":"K R\u00f6ltgen","year":"2020","journal-title":"Sci Immunol"},{"issue":"175","key":"pone.0254667.ref017","doi-asserted-by":"crossref","first-page":"20200683","DOI":"10.1098\/rsif.2020.0683","article-title":"Trajectory of individual immunity and vaccination required for SARS-CoV-2 community immunity: a conceptual investigation","volume":"18","author":"CM Saad-Roy","year":"2021","journal-title":"J R Soc Interface"},{"key":"pone.0254667.ref018","article-title":"Seroprevalence and attainment of herd immunity against SARS CoV-2: A modelling study","author":"A Paul","journal-title":"medRxiv"},{"key":"pone.0254667.ref019","unstructured":"https:\/\/www.fda.gov\/medical-devices\/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices\/eua-authorized-serology-test-performance."},{"issue":"2","key":"pone.0254667.ref020","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/trf.16172","article-title":"Decrease in serum antibodies to SARS-CoV-2 in convalescent plasma donors over time","volume":"61","author":"K Prus","year":"2021","journal-title":"Transfusion"},{"issue":"16","key":"pone.0254667.ref021","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1001\/jama.2020.18598","article-title":"Change in Donor Characteristics and Antibodies to SARS-CoV-2 in Donated Blood in the US, June-August 2020","volume":"324","author":"RY Dodd","year":"2020","journal-title":"JAMA"},{"key":"pone.0254667.ref022","article-title":"Seroprevalence of Antibodies to SARS-CoV-2 in US Blood Donors","author":"RR Vassallo","journal-title":"medRxiv"},{"issue":"4","key":"pone.0254667.ref023","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1537-2995.2011.03353.x","article-title":"Demographics of Successful, Unsuccessful and Deferral Visits at Six Blood Centers over a Four-Year Period","volume":"52","author":"B Custer","year":"2012","journal-title":"Transfusion"},{"issue":"9","key":"pone.0254667.ref024","doi-asserted-by":"crossref","first-page":"e146148","DOI":"10.1172\/jci.insight.146148","article-title":"Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure","volume":"6","author":"AR Demonbreun","year":"2021","journal-title":"JCI Insight"},{"key":"pone.0254667.ref025","first-page":"e207976","article-title":"Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020","author":"KL Bajema","year":"2020","journal-title":"JAMA Intern Med"},{"key":"pone.0254667.ref026","doi-asserted-by":"crossref","unstructured":"Kline D, Li Z, Chu Y, Wakefield J, Miller WC, Turner AN, et al. Estimating Seroprevalence of SARS-CoV-2 in Ohio: A Bayesian Multilevel Poststratification Approach with Multiple Diagnostic Tests. 2020. arXiv:2011.09033.","DOI":"10.1073\/pnas.2023947118"},{"key":"pone.0254667.ref027","article-title":"Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals","author":"C Manisty","year":"2021","journal-title":"The Lancet"},{"issue":"4","key":"pone.0254667.ref028","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.bpj.2018.01.002","article-title":"HullRad: Fast Calculations of Folded and Disordered Protein and Nucleic Acid Hydrodynamic Properties","volume":"114","author":"PJ Fleming","year":"2018","journal-title":"Biophys J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0254667","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T13:30:20Z","timestamp":1626269420000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0254667"}},"subtitle":[],"editor":[{"given":"Binod","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0254667","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.03.11.21253263","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]}}}